Approval · Notice of Compliance 10577 · 2009
CAYSTON: Notice of Compliance 10577
Issued September 11, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
Issued with conditions (NOC/c): the company must confirm the benefit in further studies.
- Notice number
- 10577
- Date
- September 11, 2009
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antibiotic
- With conditions
- Yes (NOC/c)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CAYSTON | 02329840 | Marketed |
Medicinal ingredients
- AZTREONAM 75 MG per VIAL